Showing 1,861 - 1,880 results of 42,560 for search '(( a point decrease ) OR ( 50 ((((we decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.21s Refine Results
  1. 1861
  2. 1862
  3. 1863
  4. 1864
  5. 1865
  6. 1866
  7. 1867
  8. 1868

    Quantitative Influenza Follow-Up Testing (QIFT)—A Novel Biomarker for the Monitoring of Disease Activity at the Point-of-Care by Xi Chen (35903)

    Published 2014
    “…A “switch” from positive to negative values may indicate a drop in viral load below a critical threshold, where rebound is no longer expected. …”
  9. 1869
  10. 1870

    S1 Dataset - by Siwar Garrouch (15426810)

    Published 2023
    “…</p><p>Results</p><p>We have pointed out a significant decrease in both total and progressive sperm motility during COVID-19 pandemic (p<0.0001 and p = 0.001 respectively). …”
  11. 1871
  12. 1872
  13. 1873
  14. 1874

    Combining stabilizing point mutations from different Env variants produces a hyperstable virus, comb-mut. by Daniel P. Leaman (105329)

    Published 2013
    “…(<b>B</b>) The relative resistance of comb-mut to ligand-induced infectivity decay is shown as a function of the fold decrease in IC50 after 20 hour pre-incubation relative to 1 hour pre-incubation as described in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1003184#ppat-1003184-g008" target="_blank"><b>Figure 8</b></a>. …”
  15. 1875
  16. 1876
  17. 1877

    N2142A mutation reduced viral replication and binding to cell by impairing receptor binding. by Xue Li (285380)

    Published 2023
    “…RD cells were infected at a MOI of 0.01 and viral titers were determined at the indicated time points post infection. …”
  18. 1878
  19. 1879

    The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis-0 by Adam I Riker (92580)

    Published 2011
    “…<p><b>Copyright information:</b></p><p>Taken from "The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis"</p><p>http://www.biomedcentral.com/1755-8794/1/13</p><p>BMC Medical Genomics 2008;1():13-13.…”
  20. 1880